UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 300

Sortiert nach

Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association

Diabetes care, 2015-10, Vol.38 (10), p.1964-1974

2015

Link zum Volltext

Verfügbarkeit prüfen

Prevalence, Characteristics and Clinical Diagnosis of Maturity Onset Diabetes of the Young Due to Mutations in HNF1A, HNF4A, and Glucokinase: Results From the SEARCH for Diabetes in Youth

The journal of clinical endocrinology and metabolism, 2013-10, Vol.98 (10), p.4055-4062

2013

Link zum Volltext

Verfügbarkeit prüfen

A standardized metric to enhance clinical trial design and outcome interpretation in type 1 diabetes

Nature communications, 2023-11, Vol.14 (1), p.7214-7214, Article 7214

2023

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of detectable C-Peptide according to age at diagnosis and duration of type 1 diabetes

Diabetes care, 2015-03, Vol.38 (3), p.476-481

2015

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials

The Lancet (British edition), 2013-06, Vol.381 (9881), p.1905-1915

2013

Link zum Volltext

Verfügbarkeit prüfen

Testing a new platform to screen disease-modifying therapy in type 1 diabetes

PloS one, 2023-12, Vol.18 (12), p.e0293268-e0293268

2023

Link zum Volltext

Verfügbarkeit prüfen

Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of β-Cell Function in Therapeutic Trials in Type 1 Diabetes

Diabetes care, 2008-10, Vol.31 (10), p.1966-1971

2008

Link zum Volltext

Verfügbarkeit prüfen

Autoreactive T cells specific for insulin B:11-23 recognize a low-affinity peptide register in human subjects with autoimmune diabetes

Proceedings of the National Academy of Sciences - PNAS, 2014-10, Vol.111 (41), p.14840-14845

2014

Link zum Volltext

Verfügbarkeit prüfen

Citrullination of glucokinase is linked to autoimmune diabetes

Nature communications, 2022-04, Vol.13 (1), p.1870-1870, Article 1870

2022

Link zum Volltext

Verfügbarkeit prüfen

Sensitive detection of multiple islet autoantibodies in type 1 diabetes using small sample volumes by agglutination-PCR

PloS one, 2020-11, Vol.15 (11), p.e0242049-e0242049

2020

Link zum Volltext

Verfügbarkeit prüfen

A Key to T1D Prevention: Screening and Monitoring Relatives as Part of Clinical Care

Diabetes (New York, N.Y.), 2021-05, Vol.70 (5), p.1029-1037

Greenbaum, Carla J

2021

Link zum Volltext

Verfügbarkeit prüfen

Insulin is necessary but not sufficient: changing the therapeutic paradigm in type 1 diabetes [version 1; peer review: 5 approved]

F1000 research, 2020, Vol.9, p.827

2020

Link zum Volltext

Verfügbarkeit prüfen

Characterizing T cell responses to enzymatically modified beta cell neo-epitopes

Frontiers in immunology, 2023-01, Vol.13, p.1015855-1015855

2023

Link zum Volltext

Verfügbarkeit prüfen

Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial

The lancet. Diabetes & endocrinology, 2013-12, Vol.1 (4), p.284-294

2013

Link zum Volltext

Verfügbarkeit prüfen

IL-6-Driven pSTAT1 Response Is Linked to T Cell Features Implicated in Early Immune Dysregulation

Frontiers in immunology, 2022-07, Vol.13, p.935394-935394

2022

Link zum Volltext

Verfügbarkeit prüfen

Approval of teplizumab: implications for patients

Nature reviews. Endocrinology, 2023-07, Vol.19 (7), p.377-378

2023

Link zum Volltext

Verfügbarkeit prüfen

Preservation of β-Cell Function in Autoantibody-Positive Youth With Diabetes

Diabetes care, 2009-10, Vol.32 (10), p.1839-1844

2009

Link zum Volltext

Verfügbarkeit prüfen

Genetics Coming of Age in Type 1 Diabetes

Diabetes care, 2019-02, Vol.42 (2), p.189-191

2019

Link zum Volltext

Verfügbarkeit prüfen

Sample size requirements for studies of treatment effects on beta-cell function in newly diagnosed type 1 diabetes

PloS one, 2011-11, Vol.6 (11), p.e26471

2011

Link zum Volltext

Verfügbarkeit prüfen

Systematic Assessment of Immune Marker Variation in Type 1 Diabetes: A Prospective Longitudinal Study

Frontiers in immunology, 2019-09, Vol.10, p.2023-2023

2019

Link zum Volltext

Verfügbarkeit prüfen

An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

The New England journal of medicine, 2019-08, Vol.381 (7), p.603-613

2019

Link zum Volltext

Verfügbarkeit prüfen

Fall in C-Peptide During First 4 Years From Diagnosis of Type 1 Diabetes: Variable Relation to Age, HbA1c, and Insulin Dose

Diabetes care, 2016-10, Vol.39 (10), p.1664-1670

2016

Link zum Volltext

Verfügbarkeit prüfen

Islet-autoreactive CD4+ T cells are linked with response to alefacept in type 1 diabetes

JCI insight, 2023-11, Vol.8 (21)

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 300

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(296)
Mit Volltextzugriff
(275)

Publikationsform

Artikel
(300)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(219)
Science & Technology
(212)
Life Sciences & Biomedicine
(197)
Diabetes
(130)
Female
(127)
Male
(126)
Endocrinology & Metabolism
(111)
Adolescent
(104)
Adult
(101)
Child
(100)
Type 1 Diabetes
(82)
Diabetes Mellitus
(69)
Biological And Medical Sciences
(68)
Young Adult
(68)
Medical Sciences
(65)
Diabetes Mellitus, Type 1 - Immunology
(61)
Endocrinopathies
(55)
Diabetes. Impaired Glucose Tolerance
(54)
Endocrine Pancreas. Apud Cells
(54)
Insulin
(54)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Diabetes Care
(63)
Diabetes
(51)
The Journal Of Clinical Endocrinology And Metabolism
(15)
The Journal Of Immunology
(13)
Pediatric Diabetes
(9)
Diabetologia
(8)
Plos One
(7)
The Journal Of Clinical Investigation
(7)
Jci Insight
(6)
The Journal Of Pediatrics
(6)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association

Prevalence, Characteristics and Clinical Diagnosis of Maturity Onset Diabetes of the Young Due to Mutations in HNF1A, HNF4A, and Glucokinase: Results From the SEARCH for Diabetes in Youth

A standardized metric to enhance clinical trial design and outcome interpretation in type 1 diabetes

Prevalence of detectable C-Peptide according to age at diagnosis and duration of type 1 diabetes

Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

Testing a new platform to screen disease-modifying therapy in type 1 diabetes

Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of β-Cell Function in Therapeutic Trials in Type 1 Diabetes

Autoreactive T cells specific for insulin B:11-23 recognize a low-affinity peptide register in human subjects with autoimmune diabetes

Citrullination of glucokinase is linked to autoimmune diabetes

Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial

Sensitive detection of multiple islet autoantibodies in type 1 diabetes using small sample volumes by agglutination-PCR

A Key to T1D Prevention: Screening and Monitoring Relatives as Part of Clinical Care

Insulin is necessary but not sufficient: changing the therapeutic paradigm in type 1 diabetes [version 1; peer review: 5 approved]

Characterizing T cell responses to enzymatically modified beta cell neo-epitopes

Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial

IL-6-Driven pSTAT1 Response Is Linked to T Cell Features Implicated in Early Immune Dysregulation

Approval of teplizumab: implications for patients

Preservation of β-Cell Function in Autoantibody-Positive Youth With Diabetes

Genetics Coming of Age in Type 1 Diabetes

Sample size requirements for studies of treatment effects on beta-cell function in newly diagnosed type 1 diabetes

Systematic Assessment of Immune Marker Variation in Type 1 Diabetes: A Prospective Longitudinal Study

An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

Fall in C-Peptide During First 4 Years From Diagnosis of Type 1 Diabetes: Variable Relation to Age, HbA1c, and Insulin Dose

Islet-autoreactive CD4+ T cells are linked with response to alefacept in type 1 diabetes

Suchergebnisse filtern